Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IB-Relieve is a dietary supplement formulated to support gastrointestinal health and alleviate symptoms associated with Irritable Bowel Syndrome (IBS), such as abdominal pain, bloating, and gas. Developed by Integrative Therapeutics, the product contains a synergistic blend of enteric-coated essential oils, including peppermint oil, oregano oil, and ginger extract. Peppermint oil, the primary active component, acts as a smooth muscle relaxant in the gastrointestinal tract by inhibiting L-type calcium channels, thereby reducing spasms. Oregano oil provides antimicrobial properties that may help maintain a healthy balance of intestinal microflora, while ginger extract acts on serotonergic receptors (5-HT3 and 5-HT4) to support gastric motility and reduce nausea. The enteric coating is a critical formulation feature, ensuring that the volatile oils bypass the stomach to be released in the small intestine, which minimizes the risk of gastroesophageal reflux and heartburn.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on IB-Relieve.